Nemsis Pharmaceuticals (I) Private Limited

Nemsis Pharmaceuticals (I) Private Limited - pharma in Kurnool, Andhra Pradesh, India. FY 2026 financials & compliance.
CIN U33111AP2015PTC096801 Incorporated 08 June 2015 ROC Vijayawada HQ Kurnool, Andhra Pradesh, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹70.57 Lakh
▼ 19% YoY
Net loss · FY 2024
₹3.62 Lakh
Net margin -5.1%
EBITDA · FY 2024
-₹3.56 Lakh
EBITDA margin -5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Nemsis Pharmaceuticals (I) Private Limited

Data last updated:

Nemsis Pharmaceuticals (I) Private Limited is a private limited company based in Kurnool, Andhra Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 June 2015 and has been in existence for over 11 years.

The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U33111AP2015PTC096801. Its GSTIN is 37AAECN9600L1Z5 (Andhra Pradesh).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Venkata Subba Siva Prakash Vinayakula and Dhanalakshmamma Vinayakula.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No. 78/129/B1 Old No. 109/130 Krishna Nagar, Kurnool, Andhra Pradesh, India – 518002.

As per the financials filed for FY 2024, the company reported a revenue of ₹70.57 Lakh, a decline of 19% compared to the previous year. For the same year it recorded a net loss of ₹3.62 Lakh (net margin -5.1%) and EBITDA of -₹3.56 Lakh (EBITDA margin -5%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 23% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Nemsis Pharmaceuticals (I) Private Limited
CIN U33111AP2015PTC096801
Registration Number 096801
Incorporation Date 08 June 2015
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    H No. 78/129/B1 Old No. 109/130 Krishna Nagar, Kurnool, Andhra Pradesh, India – 518002
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Nemsis Pharmaceuticals (I) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Nemsis Pharmaceuticals (I) Private Limited report

Financials, compliance, directors, charges, ownership and filings for Nemsis Pharmaceuticals (I) Private Limited in one report.

Financials from FY 2016 Directors & ownership Charges & compliance

Business Activity of Nemsis Pharmaceuticals (I) Private Limited

The main business activity of Nemsis Pharmaceuticals (I) is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GWholesale and retail trade; repair of motor vehicles and motorcycles45Wholesale and retail trade and repair of motor vehicles and motorcyclesLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Nemsis Pharmaceuticals (I) Private Limited FY 2025 filings available

Nemsis Pharmaceuticals (I) Private Limited reported revenue of ₹70.57 Lakh (down 19% YoY) for FY 2024.

Revenue · FY 2024
₹70.57 Lakh ▼ 19%
Net loss · FY 2024
₹3.62 Lakh margin -5.1%
EBITDA · FY 2024
-₹3.56 Lakh margin -5%

Compounded Annual Growth Rate (CAGR) of Nemsis Pharmaceuticals (I) Private Limited

Revenue CAGR growth
1 year
▼ 19%
3 years · compounded
▲ 2%
5 years · compounded
▲ 23%
EBITDA CAGR growth
1 year
▼ 80%
3 years · compounded
▼ 215%
5 years · compounded
▼ 34%

Revenue fell 19% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 23%. EBITDA fell 80% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Nemsis Pharmaceuticals (I) Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA-₹3.56 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)-₹3.62 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Nemsis Pharmaceuticals (I) Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin-5%••••••••••••••••
Net Profit Margin-5.1%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nemsis Pharmaceuticals (I) are in the company report.

Premium access

Financial statements from FY 2016

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Nemsis Pharmaceuticals (I) Private Limited

Nemsis Pharmaceuticals (I) has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Venkata Subba Siva Prakash VinayakulaDirector08 Jun 201511 Years 4 MonthsCurrent
Dhanalakshmamma VinayakulaDirector08 Jun 201511 Years 4 MonthsCurrent

Peer Comparison of Nemsis Pharmaceuticals (I) Private Limited

Nemsis Pharmaceuticals (I) Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Vizag Pharmaceuticals Private Limited₹70.81 Lakh (FY 2016)••••••••-52.0%••••Hyderabad, Telangana, India
Ecstatic Pharmaceuticals Private Limited₹70.76 Lakh (FY 2023)••••••••13.0%••••Thane, Maharashtra, India
Physa Pharmaceuticals Private Limited₹70.69 Lakh (FY 2025)••••••••8.0%••••Noida, Uttar Pradesh, India
Medimyelin Pharmaceuticals Private Limited₹70.63 Lakh (FY 2024)••••••••695.0%••••Guwahati, Assam, India
Trigger Marketing Limited₹70.62 Lakh (FY 2023)••••••••-87.0%••••Coimbatore, Tamil Nadu, India
Nemsis Pharmaceuticals (I) Private Limited this company₹70.57 Lakh (FY 2024)••••••••-19.0%••••Kurnool, Andhra Pradesh, India
Hahnemann Pharmaceuticals Private Limited₹70.46 Lakh (FY 2024)••••••••28.0%••••New Delhi, Delhi, India
Arm Accro Marketing Private Limited₹70.46 Lakh (FY 2021)••••••••207.0%••••Delhi, India
Amsperry Healthcare Private Limited₹70.41 Lakh (FY 2025)••••••••••••Ernakulam, Kerala, India
Fender Formulations Private Limited₹70.38 Lakh (FY 2023)••••••••3.0%••••Bhiwandi, Maharashtra, India
Trueboon Pharma Private Limited₹70.35 Lakh (FY 2025)••••••••2422.0%••••Jaipur, Rajasthan, India

Peers are the five companies nearest above and the five nearest below Nemsis Pharmaceuticals (I) by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Nemsis Pharmaceuticals (I) Private Limited

Nemsis Pharmaceuticals (I) Private Limited is audited by GHANTASALA & CO for the financial year 2020.

NameStatusAppointment DateCessation Date
GHANTASALA & COLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Nemsis Pharmaceuticals (I) Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Nemsis Pharmaceuticals (I) Private Limited

Nemsis Pharmaceuticals (I) Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Nemsis Pharmaceuticals (I) Private Limited

Employment history and EPFO contributions of people linked to Nemsis Pharmaceuticals (I).

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Nemsis Pharmaceuticals (I) Private Limited

Nemsis Pharmaceuticals (I) Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Dhanalakshmamma Vinayakula was appointed as Director on 08 Jun 2015.

AGM
Nemsis Pharmaceuticals (I) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nemsis Pharmaceuticals (I) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada.
Appointed
Dhanalakshmamma Vinayakula was appointed as Director.
Appointed
Venkata Subba Siva Prakash Vinayakula was appointed as Director.
Incorporation
08 Jun 2015
Nemsis Pharmaceuticals (I) Private Limited was registered on 08 Jun 2015 with Roc Vijayawada & aged 11 years 4 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Nemsis Pharmaceuticals (I) Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Nemsis Pharmaceuticals (I) Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Nemsis Pharmaceuticals (I) Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Nemsis Pharmaceuticals (I) Private Limited

Nemsis Pharmaceuticals (I) has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
37AAECN9600L1Z5Andhra PradeshActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Nemsis Pharmaceuticals (I) Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nemsis Pharmaceuticals (I) Private Limited

Nemsis Pharmaceuticals (I) is an active private limited company based in Kurnool, Andhra Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 June 2015 (11+ years old) and is registered under CIN U33111AP2015PTC096801.

Nemsis Pharmaceuticals (I) reported revenue of ₹70.57 Lakh for FY 2024 (down 19% YoY).

Nemsis Pharmaceuticals (I) has 2 current directors:

Nemsis Pharmaceuticals (I) reported a net loss of ₹3.62 Lakh (net margin -5.1%) and EBITDA of -₹3.56 Lakh (EBITDA margin -5%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Nemsis Pharmaceuticals (I) is 2% over three years and 23% over five years. In the latest year (FY 2024) revenue fell 19%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Nemsis Pharmaceuticals (I) is 37AAECN9600L1Z5, registered in Andhra Pradesh.

The CIN (Corporate Identification Number) of Nemsis Pharmaceuticals (I) is U33111AP2015PTC096801. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Nemsis Pharmaceuticals (I) was incorporated on 08 June 2015, making it 11+ years old. It is registered with the Registrar of Companies, Vijayawada.

The peers of Nemsis Pharmaceuticals (I) by revenue are Vizag Pharmaceuticals Private Limited, Ecstatic Pharmaceuticals Private Limited, Physa Pharmaceuticals Private Limited, Medimyelin Pharmaceuticals Private Limited, Trigger Marketing Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).

Dhanalakshmamma Vinayakula was appointed as Director on 08 Jun 2015. Venkata Subba Siva Prakash Vinayakula was appointed as Director on 08 Jun 2015.

The registered office of Nemsis Pharmaceuticals (I) is at H No. 78129B1 Old No. 109130 Krishna Nagar, Kurnool, Andhra Pradesh, India – 518002.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available